Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapies

Myriam Lemmens, Lena Dorsheimer, Andreas Zeller, Yasmin Dietz-Baum (2024) Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapies Mutat Res Genet Toxicol Environ Mutagen (IF: 3) 896 503767